Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 136 AL 150

What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus

Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative.

Prog Neurobiol. 2014 Jun;117:20-40. doi: 10.1016/j.pneurobio.2014.02.004. Epub 2014 Feb 16.

Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study

Canevelli M, Adali N, Kelaiditi E, Cantet C, Ousset PJ, Cesari M; ICTUS/DSA Group.

Phytomedicine. 2014 May 15;21(6):888-92. doi: 10.1016/j.phymed.2014.01.003. Epub 2014 Feb 16.

Wnt signaling in the nervous system and in Alzheimer's disease

Inestrosa NC, Varela-Nallar L.

J Mol Cell Biol. 2014 Feb;6(1):64-74. doi: 10.1093/jmcb/mjt051.

D-amino acid-based peptide inhibitors as early or preventative therapy in Alzheimer disease

Kumar J, Sim V.

Prion. 2014 Jan-Feb;8(1):119-24. doi: 10.4161/pri.28220.

Cellular membrane fluidity in amyloid precursor protein processing

Yang X, Sun GY, Eckert GP, Lee JC.

Mol Neurobiol. 2014 Aug;50(1):119-29. doi: 10.1007/s12035-014-8652-6. Epub 2014 Feb 20.

Network-wide dysregulation of calcium homeostasis in Alzheimer's disease

Brawek B, Garaschuk O.

Cell Tissue Res. 2014 Aug;357(2):427-38. doi: 10.1007/s00441-014-1798-8. Epub 2014 Feb 20.

Targeting the β secretase BACE1 for Alzheimer's disease therapy

Yan R, Vassar R.

Lancet Neurol. 2014 Mar;13(3):319-29. doi: 10.1016/S1474-4422(13)70276-X. Epub 2014 Feb 17.

Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment

Serpente M, Bonsi R, Scarpini E, Galimberti D.

Neuroimmunomodulation. 2014;21(2-3):79-87. doi: 10.1159/000356529. Epub 2014 Feb 14.

The role of inflammasome in Alzheimer's disease

Liu L, Chan C.

Ageing Res Rev. 2014 May;15:6-15. doi: 10.1016/j.arr.2013.12.007. Epub 2014 Feb 19.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2014 Feb 21;2014(2):CD005380. doi: 10.1002/14651858.CD005380.pub5.

Why calcium channel blockers could be an elite choice in the treatment of Alzheimer's disease: a comprehensive review of evidences

Saravanaraman P, Chinnadurai RK, Boopathy R.

Rev Neurosci. 2014;25(2):231-46. doi: 10.1515/revneuro-2013-0056.

Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease

Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK, Trivedi P.

Curr Drug Targets. 2014 May;15(5):539-50. doi: 10.2174/1389450115666140226112321.

Influence of anesthetics on Alzheimer's disease: biophysical, animal model, and clinical reports

Silverstein JH.

J Alzheimers Dis. 2014;40(4):839-48. doi: 10.3233/JAD-130815.

Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies

Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P.

ScientificWorldJournal. 2014 Jan 22;2014:174282. doi: 10.1155/2014/174282. eCollection 2014.

Retinoids as potential targets for Alzheimer's disease

Sodhi RK, Singh N.

Pharmacol Biochem Behav. 2014 May;120:117-23. doi: 10.1016/j.pbb.2014.02.016. Epub 2014 Feb 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias